The group's principal activity is to develop prescription pharmaceutical products, vaccines and vaccine adjuvants using nanoparticle technology. In addition, it is also developing a pipeline of hormone replacement products to treat hormone deficiencies in men and women. Since its inception, it has been in the development stage.
